Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.420
+0.160 (4.91%)
At close: Jun 26, 2026, 4:00 PM EDT
3.435
+0.015 (0.44%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Sana Biotechnology Employees
Sana Biotechnology had 142 employees as of December 31, 2025. The number of employees decreased by 52 or -26.80% compared to the previous year.
Employees
142
Change (1Y)
-52
Growth (1Y)
-26.80%
Revenue / Employee
n/a
Profits / Employee
-$1,704,134
Market Cap
1.03B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Pharming Group | 407 |
| Kura Oncology | 260 |
| Xencor | 260 |
| DBV Technologies | 161 |
| Olema Pharmaceuticals | 137 |
| Alpha Tau Medical | 121 |
SANA News
- 19 days ago - Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 4 weeks ago - Sana Biotechnology to Present at June 2026 Investor Conferences - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy - TheFly
- 6 weeks ago - Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs - GlobeNewsWire